{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:14:09Z","timestamp":1773260049395,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10300-3","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T05:01:44Z","timestamp":1700715704000},"page":"3686-3698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Seung Yoon","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heejin","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyunghwa","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Dae","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Soo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk","family":"Hur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Soh","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-5042","authenticated-orcid":false,"given":"Joon Seok","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"10300_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1200\/JCO.2014.60.1054","volume":"33","author":"JJ Smith","year":"2015","unstructured":"Smith JJ, Garcia-Aguilar J (2015) Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol 33:1797\u20131808","journal-title":"J Clin Oncol"},{"key":"10300_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1148\/radiol.13121361","volume":"268","author":"S Nougaret","year":"2013","unstructured":"Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G (2013) The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the \u201cDISTANCE\u201d? Radiology 268:330\u2013344","journal-title":"Radiology"},{"key":"10300_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","volume":"1","author":"RJ Heald","year":"1986","unstructured":"Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479\u20131482","journal-title":"Lancet"},{"key":"10300_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/NEJMoa010580","volume":"345","author":"E Kapiteijn","year":"2001","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638\u2013646","journal-title":"N Engl J Med"},{"key":"10300_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","volume":"253","author":"FG Taylor","year":"2011","unstructured":"Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711\u2013719","journal-title":"Ann Surg"},{"key":"10300_CR6","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","volume":"26","author":"M Braendengen","year":"2008","unstructured":"Braendengen M, Tveit KM, Berglund A et al (2008) Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26:3687\u20133694","journal-title":"J Clin Oncol"},{"key":"10300_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S1470-2045(14)70377-8","volume":"15","author":"YS Hong","year":"2014","unstructured":"Hong YS, Nam BH, Kim KP et al (2014) Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Lancet Oncol 15:1245\u20131253","journal-title":"Lancet Oncol"},{"key":"10300_CR8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/bjs.5506","volume":"93","author":"K Bujko","year":"2006","unstructured":"Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215\u20131223","journal-title":"Br J Surg"},{"key":"10300_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"KC Peeters","year":"2007","unstructured":"Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693\u2013701","journal-title":"Ann Surg"},{"issue":"3","key":"10300_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/ijms18030573","volume":"18","author":"D Dayde","year":"2017","unstructured":"Dayde D, Tanaka I, Jain R, Tai MC, Taguchi A (2017) Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer. Int J Mol Sci 18(3):573","journal-title":"Int J Mol Sci"},{"key":"10300_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc.2016.126","volume":"17","author":"R Dienstmann","year":"2017","unstructured":"Dienstmann R, Vermeulen L, Guinney J, Kopetz S, Tejpar S, Tabernero J (2017) Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer 17:79\u201392","journal-title":"Nat Rev Cancer"},{"key":"10300_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21:1350\u20131356","journal-title":"Nat Med"},{"key":"10300_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/bjc.2013.603","volume":"110","author":"M Chand","year":"2014","unstructured":"Chand M, Swift RI, Tekkis PP, Chau I, Brown G (2014) Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 110:19\u201325","journal-title":"Br J Cancer"},{"key":"10300_CR14","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/17474124.2016.1179577","volume":"10","author":"C Hunter","year":"2016","unstructured":"Hunter C, Brown G (2016) Pre-operative staging of rectal cancer: a review of imaging techniques. Expert Rev Gastroenterol Hepatol 10:1011\u20131025","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10300_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/bjs.1800670619","volume":"67","author":"IC Talbot","year":"1980","unstructured":"Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC (1980) The clinical significance of invasion of veins by rectal cancer. Br J Surg 67:439\u2013442","journal-title":"Br J Surg"},{"key":"10300_CR16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/DCR.0000000000000162","volume":"57","author":"KM Gibson","year":"2014","unstructured":"Gibson KM, Chan C, Chapuis PH, Dent OF, Bokey L (2014) Mural and extramural venous invasion and prognosis in colorectal cancer. Dis Colon Rectum 57:916\u2013926","journal-title":"Dis Colon Rectum"},{"key":"10300_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/bjs.4034","volume":"90","author":"G Brown","year":"2003","unstructured":"Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90:355\u2013364","journal-title":"Br J Surg"},{"key":"10300_CR18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2214\/AJR.08.1298","volume":"191","author":"NJ Smith","year":"2008","unstructured":"Smith NJ, Shihab O, Arnaout A, Swift RI, Brown G (2008) MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol 191:1517\u20131522","journal-title":"AJR Am J Roentgenol"},{"key":"10300_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13244-022-01316-2","volume":"13","author":"J Fang","year":"2022","unstructured":"Fang J, Sun W, Wu D et al (2022) Value of texture analysis based on dynamic contrast-enhanced magnetic resonance imaging in preoperative assessment of extramural venous invasion in rectal cancer. Insights Imaging 13:179","journal-title":"Insights Imaging"},{"key":"10300_CR20","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/bjc.2017.99","volume":"116","author":"MRS Siddiqui","year":"2017","unstructured":"Siddiqui MRS, Simillis C, Hunter C et al (2017) A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. Br J Cancer 116:1513\u20131519","journal-title":"Br J Cancer"},{"key":"10300_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/bjs.5917","volume":"95","author":"NJ Smith","year":"2008","unstructured":"Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G (2008) Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 95:229\u2013236","journal-title":"Br J Surg"},{"key":"10300_CR22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00330-014-3527-9","volume":"25","author":"B Sohn","year":"2015","unstructured":"Sohn B, Lim JS, Kim H et al (2015) MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 25:1347\u20131355","journal-title":"Eur Radiol"},{"key":"10300_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1148\/radiol.2018172889","volume":"289","author":"XY Zhang","year":"2018","unstructured":"Zhang XY, Wang S, Li XT et al (2018) MRI of extramural venous invasion in locally advanced rectal cancer: relationship to tumor recurrence and overall survival. Radiology 289:677\u2013685","journal-title":"Radiology"},{"key":"10300_CR24","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1007\/s00330-021-07981-z","volume":"31","author":"S Chen","year":"2021","unstructured":"Chen S, Li N, Tang Y et al (2021) The prognostic value of MRI-detected extramural vascular invasion (mrEMVI) for rectal cancer patients treated with neoadjuvant therapy: a meta-analysis. Eur Radiol 31:8827\u20138837","journal-title":"Eur Radiol"},{"key":"10300_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/jjco\/hyv208","volume":"46","author":"KH Kim","year":"2016","unstructured":"Kim KH, Park MJ, Lim JS et al (2016) Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia. Jpn J Clin Oncol 46:316\u2013322","journal-title":"Jpn J Clin Oncol"},{"key":"10300_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiol.2272011747","volume":"227","author":"G Brown","year":"2003","unstructured":"Brown G, Richards CJ, Bourne MW et al (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227:371\u2013377","journal-title":"Radiology"},{"key":"10300_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3857\/roj.2013.31.1.41","volume":"31","author":"JS Chang","year":"2013","unstructured":"Chang JS, Yoon HI, Cha HJ et al (2013) Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner. Radiat Oncol J 31:41\u201347","journal-title":"Radiat Oncol J"},{"key":"10300_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.radonc.2010.02.003","volume":"95","author":"SJ Shin","year":"2010","unstructured":"Shin SJ, Kim NK, Keum KC et al (2010) Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer. Radiother Oncol 95:303\u2013307","journal-title":"Radiother Oncol"},{"key":"10300_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00464-009-0656-3","volume":"24","author":"YA Park","year":"2010","unstructured":"Park YA, Kim JM, Kim SA et al (2010) Totally robotic surgery for rectal cancer: from splenic flexure to pelvic floor in one setup. Surg Endosc 24:715\u2013720","journal-title":"Surg Endosc"},{"key":"10300_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.suronc.2015.06.012","volume":"24","author":"NK Kim","year":"2015","unstructured":"Kim NK, Kim YW, Cho MS (2015) Total mesorectal excision for rectal cancer with emphasis on pelvic autonomic nerve preservation: expert technical tips for robotic surgery. Surg Oncol 24:172\u2013180","journal-title":"Surg Oncol"},{"key":"10300_CR31","doi-asserted-by":"publisher","first-page":"874","DOI":"10.6004\/jnccn.2018.0061","volume":"16","author":"AB Benson 3rd","year":"2018","unstructured":"Benson AB 3rd, Venook AP, Al-Hawary MM et al (2018) Rectal cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16:874\u2013901","journal-title":"J Natl Compr Canc Netw"},{"key":"10300_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4174\/astr.2014.86.3.143","volume":"86","author":"JP Ryuk","year":"2014","unstructured":"Ryuk JP, Choi GS, Park JS et al (2014) Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection. Ann Surg Treat Res 86:143\u2013151","journal-title":"Ann Surg Treat Res"},{"key":"10300_CR33","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1090\/S0002-9947-1943-0012401-3","volume":"54","author":"A Wald","year":"1943","unstructured":"Wald A (1943) Tests of statistical hypotheses concerning several parameters when the number of observations is large. Trans Am Math Soc 54:426\u2013482","journal-title":"Trans Am Math Soc"},{"key":"10300_CR34","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1200\/JCO.2015.63.3651","volume":"33","author":"KV Ballman","year":"2015","unstructured":"Ballman KV (2015) Biomarker: predictive or prognostic? J Clin Oncol 33:3968\u20133971","journal-title":"J Clin Oncol"},{"key":"10300_CR35","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ et al (2022) Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 40:2546\u20132556","journal-title":"J Clin Oncol"},{"key":"10300_CR36","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJM van der Valk","year":"2018","unstructured":"van der Valk MJM, Hilling DE, Bastiaannet E et al (2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 391:2537\u20132545","journal-title":"Lancet"},{"key":"10300_CR37","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s10350-007-0247-0","volume":"50","author":"YB Cho","year":"2007","unstructured":"Cho YB, Chun HK, Yun HR, Lee WS, Yun SH, Lee WY (2007) Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Colon Rectum 50:1204\u20131210","journal-title":"Dis Colon Rectum"},{"key":"10300_CR38","first-page":"546","volume":"30","author":"ME Salem","year":"2016","unstructured":"Salem ME, Hartley M, Unger K, Marshall JL (2016) Neoadjuvant combined-modality therapy for locally advanced rectal cancer and its future direction. Oncology (Williston Park) 30:546\u2013562","journal-title":"Oncology (Williston Park)"},{"key":"10300_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0002-9610(81)90004-0","volume":"141","author":"IC Talbot","year":"1981","unstructured":"Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC (1981) Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg 141:15\u201317","journal-title":"Am J Surg"},{"key":"10300_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1743-7563.2010.01275.x","volume":"6","author":"M Aghili","year":"2010","unstructured":"Aghili M, Izadi S, Madani H, Mortazavi H (2010) Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol 6:35\u201341","journal-title":"Asia Pac J Clin Oncol"},{"key":"10300_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.6004\/jnccn.2014.0056","volume":"12","author":"A Cercek","year":"2014","unstructured":"Cercek A, Goodman KA, Hajj C et al (2014) Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw 12:513\u2013519","journal-title":"J Natl Compr Canc Netw"},{"key":"10300_CR42","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1200\/JCO.2005.04.4875","volume":"24","author":"I Chau","year":"2006","unstructured":"Chau I, Brown G, Cunningham D et al (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24:668\u2013674","journal-title":"J Clin Oncol"},{"key":"10300_CR43","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/annonc\/mds010","volume":"23","author":"R Glynne-Jones","year":"2012","unstructured":"Glynne-Jones R, Anyamene N, Moran B, Harrison M (2012) Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation? Ann Oncol 23:2517\u20132526","journal-title":"Ann Oncol"},{"key":"10300_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000003471","author":"F Petrelli","year":"2019","unstructured":"Petrelli F, Trevisan F, Cabiddu M et al (2019) Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg. https:\/\/doi.org\/10.1097\/sla.0000000000003471","journal-title":"Ann Surg"},{"key":"10300_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/DCR.0000000000000849","volume":"60","author":"P Rouanet","year":"2017","unstructured":"Rouanet P, Rullier E, Lelong B et al (2017) Tailored treatment strategy for locally advanced rectal carcinoma based on the tumor response to induction chemotherapy: preliminary results of the French Phase II Multicenter GRECCAR4 trial. Dis Colon Rectum 60:653\u2013663","journal-title":"Dis Colon Rectum"},{"key":"10300_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/SLA.0000000000000848","volume":"261","author":"M Chand","year":"2015","unstructured":"Chand M, Evans J, Swift RI et al (2015) The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg 261:473\u2013479","journal-title":"Ann Surg"},{"key":"10300_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B et al (2021) Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 22:29\u201342","journal-title":"Lancet Oncol"},{"key":"10300_CR48","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL et al (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22:702\u2013715","journal-title":"Lancet Oncol"},{"key":"10300_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/DCR.0000000000000001","volume":"57","author":"M Chand","year":"2014","unstructured":"Chand M, Moran BJ, Jones RG, Heald RJ, Brown G (2014) Lymph node status does not predict local recurrence in the total mesorectal excision era. Dis Colon Rectum 57:127\u2013129","journal-title":"Dis Colon Rectum"},{"key":"10300_CR50","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1016\/j.ejca.2013.03.006","volume":"49","author":"SM Engelen","year":"2013","unstructured":"Engelen SM, Maas M, Lahaye MJ et al (2013) Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer 49:2311\u20132320","journal-title":"Eur J Cancer"},{"key":"10300_CR51","doi-asserted-by":"crossref","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E et al (2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv22-iv40","DOI":"10.1093\/annonc\/mdx224"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10300-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T10:10:43Z","timestamp":1718100643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10300-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["10300"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10300-3","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"11 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Kang Young Lee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (Kyunghwa Han) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}